Combined phacoemulsification and viscogonio synechialysis in the management of patients with chronic angle closure glaucoma

被引：30

作者：

Razeghinejad M.R. ^{[1
]}

Feisal Rahat ^{[1
]}

机构：

[1] Poostchi Ophthalmology Research Centre, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz

来源：

International Ophthalmology | 2010年 / 30卷 / 4期

关键词：

Angle closure; Glaucoma; Goniosynechialysis; Phacoemulsification;

D O I：

10.1007/s10792-010-9353-4

中图分类号：

学科分类号：

摘要：

The purpose of this study was to evaluate the effectiveness of phacoemulsification and viscogoniosynechialysis in the management of patients with chronic angle-closure glaucoma(CACG). Fifty-six eyes of 45 recruited patients were classified into two groups: group 1 had medically controlled CACG (IOP B 21 mmHg) comprising 35 eyes and group 2 medically uncontrolled CACG (IOP[21 mmHg with maximum tolerated medications) including 21 eyes. All of the patients had at least one quadrant without peripheral anterior synechia in gonioscopy. After phacoemulsification, a viscoelastic agent was used for viscogoniasynecialysis. Success was defined as IOP B 21 mmHg with (relative success) or without (absolute success) medications. There were no statistically significant differences between the two groups regarding age and gender. In group 1, the mean IOP and number of medications declined from 16.7 plusmn; 2.9 to 14.4 plusmn; 2.9 (P0.0001) and 2.6 plusmn; 0.8 to 0.82 plusmn; 0.82 (P 0.0001), respectively. The absolute success rate at the last follow-up (9 plusmn; 5.3 months) was 40%. In group 2, the mean IOP and number of medications diminished from 27.95 plusmn; 8.1 to 15.5 plusmn; 2.8 (P0.0001) and 2.9 plusmn; 0.62 to 1.2 plusmn; 1.2 (P0.0001), respectively. The absolute success rate was 38.1% at the last followup (9.5 plusmn; 5.3 months). Postoperatively, seven patients developed pupillary fibrin formation that was treated using steroids and ND:YAG laser. In the other two patients, the medically unresponsive cystoid macular edema was treated successfully by intravitreal Bevacizumab. Combined phacoemulsification and viscogoniosynechialysis seemto be an effective surgical procedure in the treatment of patients with CACG and angle restoration whether controlled or uncontrolled by medication. © Springer Science+Business Media B.V. 2010.

引用

页码：353 / 359

页数：6

共 23 条

[1]

Lai J.S., Tham C.C., Chan J.C., The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: A prospective case series, J Glaucoma, 15, pp. 47-52, (2006)

[2]

Varma D., Adams W.E., Phelan P.S., Fraser S.G., Viscogonioplasty in patients with chronic narrow angle glaucoma, Br J Ophthalmol, 90, pp. 648-649, (2006)

[3]

Lai J.S., Tham C.C., Lam D.S., The efficacy and safety of combined phacoemulsification, intraocular lens implantation, and limited goniosynechialysis, followed by diode laser peripheral iridoplasty, in the treatment of cataract and chronic angle-closure glaucoma, J Glaucoma, 10, pp. 309-315, (2001)

[4]

Campbell D.G., Vela A., Modern goniosynechialysis for the treatment of synechial angle closure glaucoma, Ophthalmology, 91, 9, pp. 1052-1060, (1984)

[5]

Bellucci R., Perfetti S., Babighian S., Morselli S., Bonomi L., Filtration and complications after trabeculectomy and after phaco-trabeculectomy, Acta Ophthalmol Scand, SUPPL., pp. 44-45, (1997)

[6]

Foster P.J., Aung T., Nolan W.P., Machin D., Baasanhu J., Khaw P.T., Alsbirk P.H., Lee P.S., Seah S.K., Johnson G.J., Defining quot

[7]

occludablequot

[8]

angles in population surveys: Drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people, Br J Ophthalmol, 88, pp. 486-490, (2004)

[9]

Hayashi K., Hayashi H., Nakao F., Hayashi F., Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma, Ophthalmology, 107, pp. 698-703, (2000)

[10]

Imaizumi M., Takaki Y., Yamashita H., Phacoemulsification and intraocular lens implantation for acute angle closure not treated or previously treated by laser iridotomy, J Cataract Refract Surg, 32, pp. 85-90, (2006)

← 1 2 3 →